These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 3143562

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of vigabatrin (gamma-vinyl GABA) on amino acid levels in CSF of epileptic patients.
    Pitkänen A, Matilainen R, Ruutiainen T, Lehtinen M, Riekkinen P.
    J Neurol Neurosurg Psychiatry; 1988 Nov; 51(11):1395-400. PubMed ID: 2853206
    [Abstract] [Full Text] [Related]

  • 3. Cerebrospinal fluid GABA and seizure control with vigabatrin.
    Riekkinen PJ, Ylinen A, Halonen T, Sivenius J, Pitkanen A.
    Br J Clin Pharmacol; 1989 Nov; 27 Suppl 1(Suppl 1):87S-94S. PubMed ID: 2757914
    [Abstract] [Full Text] [Related]

  • 4. Levels of total gamma-aminobutyric acid (GABA), free GABA and homocarnosine in cerebrospinal fluid of epileptic patients before and during gamma-vinyl-GABA (vigabatrin) treatment.
    Pitkänen A, Matilainen R, Ruutiainen T, Riekkinen P.
    J Neurol Sci; 1988 Dec; 88(1-3):83-93. PubMed ID: 3225631
    [Abstract] [Full Text] [Related]

  • 5. Gamma-vinyl GABA (vigabatrin): relationship between dosage, plasma concentrations, platelet GABA-transaminase inhibition, and seizure reduction in epileptic children.
    Arteaga R, Herranz JL, Valdizán EM, Armijo JA.
    Epilepsia; 1992 Dec; 33(5):923-31. PubMed ID: 1396437
    [Abstract] [Full Text] [Related]

  • 6. Administration of vigabatrin (gamma-vinyl-gamma-aminobutyric acid) affects the levels of both inhibitory and excitatory amino acids in rat cerebrospinal fluid.
    Halonen T, Pitkänen A, Riekkinen PJ.
    J Neurochem; 1990 Dec; 55(6):1870-4. PubMed ID: 2230800
    [Abstract] [Full Text] [Related]

  • 7. Specificity of vigabatrin for the GABAergic system in human epilepsy.
    Riekkinen PJ, Pitkanen A, Ylinen A, Sivenius J, Halonen T.
    Epilepsia; 1989 Dec; 30 Suppl 3():S18-22. PubMed ID: 2767015
    [Abstract] [Full Text] [Related]

  • 8. Effects of single doses of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsy.
    Menachem EB, Persson LI, Schechter PJ, Haegele KD, Huebert N, Hardenberg J, Dahlgren L, Mumford JP.
    Epilepsy Res; 1988 Dec; 2(2):96-101. PubMed ID: 3143561
    [Abstract] [Full Text] [Related]

  • 9. Somatostatin, beta-endorphin, and prolactin levels in human cerebrospinal fluid during the gamma-vinyl-GABA treatment of patients with complex partial epilepsy.
    Pitkänen A, Halonen T, Ylinen A, Riekkinen P.
    Neuropeptides; 1987 Apr; 9(3):185-95. PubMed ID: 2885776
    [Abstract] [Full Text] [Related]

  • 10. Effect of gamma-vinyl GABA treatment on cholinergic and aminergic neurotransmission and on cyclic nucleotides in human complex partial epilepsy--a CSF study.
    Riekkinen PJ, Pitkänen A, Halonen T, Lehtinen M, Ylinen A, Sivenius J.
    Prog Neuropsychopharmacol Biol Psychiatry; 1988 Apr; 12(1):81-91. PubMed ID: 2452456
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic effects of vigabatrin on cerebrospinal fluid amino acids in humans.
    Ben-Menachem E.
    Epilepsia; 1989 Apr; 30 Suppl 3():S12-4. PubMed ID: 2767013
    [Abstract] [Full Text] [Related]

  • 12. The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients.
    Ben-Menachem E, Persson LI, Schechter PJ, Haegele KD, Huebert N, Hardenberg J, Dahlgren L, Mumford JP.
    Br J Clin Pharmacol; 1989 Apr; 27 Suppl 1(Suppl 1):79S-85S. PubMed ID: 2474312
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory and excitatory amino acids in cerebrospinal fluid of chronic epileptic patients.
    Pitkänen A, Matilainen R, Halonen T, Kutvonen R, Hartikainen P, Riekkinen P.
    J Neural Transm; 1989 Apr; 76(3):221-30. PubMed ID: 2499662
    [Abstract] [Full Text] [Related]

  • 14. Effects of vigabatrin (gamma-vinyl GABA) on neurotransmission-related amino acids and on GABA and benzodiazepine receptor binding in rats.
    Halonen T, Pitkänen A, Saano V, Riekkinen PJ.
    Epilepsia; 1991 Apr; 32(2):242-9. PubMed ID: 1672276
    [Abstract] [Full Text] [Related]

  • 15. Gamma-vinyl-GABA: a single-blind trial in patients with epilepsy.
    Gram L, Lyon BB, Dam M.
    Acta Neurol Scand; 1983 Jul; 68(1):34-9. PubMed ID: 6613525
    [Abstract] [Full Text] [Related]

  • 16. Gamma-vinyl GABA (vigabatrin) in epilepsy: clinical, neurochemical, and neurophysiologic monitoring in epileptic patients.
    Ylinen A, Sivenius J, Pitkänen A, Halonen T, Partanen J, Mervaala E, Mumford JP, Riekkinen PJ.
    Epilepsia; 1992 Jul; 33(5):917-22. PubMed ID: 1396436
    [Abstract] [Full Text] [Related]

  • 17. Effect of long-term vigabatrin therapy on selected neurotransmitter concentrations in cerebrospinal fluid.
    Ben-Menachem E, Persson LI, Mumford J, Haegele KD, Huebert N.
    J Child Neurol; 1991 Jul; Suppl 2():S11-6. PubMed ID: 1719063
    [Abstract] [Full Text] [Related]

  • 18. Long-term evaluation of vigabatrin (gamma vinyl GABA) in epilepsy.
    Dam M.
    Epilepsia; 1989 Jul; 30 Suppl 3():S26-30. PubMed ID: 2767017
    [Abstract] [Full Text] [Related]

  • 19. Biochemical and clinical effects of gamma-vinyl GABA in patients with epilepsy.
    Schechter PJ, Hanke NF, Grove J, Huebert N, Sjoerdsma A.
    Neurology; 1984 Feb; 34(2):182-6. PubMed ID: 6538006
    [Abstract] [Full Text] [Related]

  • 20. Development of tolerance to the effects of vigabatrin (gamma-vinyl-GABA) on GABA release from rat cerebral cortex, spinal cord and retina.
    Neal MJ, Shah MA.
    Br J Pharmacol; 1990 Jun; 100(2):324-8. PubMed ID: 2379037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.